MediChip is a 3D-printed implant sutured onto tumors to deliver chemotherapy locally for a month, avoiding systemic side effects. The team claims treating 3,000 patients would generate $1 billion in revenue, though one speaker questions whether that projection is realistic.
Chapters
about 1.8 million new cases. By treating 3,000 patients, we hit the billion-dollar mark in revenue. Woo! And a couple of weeks later, they end up with long-term complications. This is something I experienced with my dad. And the reality is, is that 1 in 3 people will end up with cancer in their lifetime. So my team of experts from the industry, including the FDA and pharma, combined 100 years together came together for the last 5 years to make MediChip. MediChip is a 3D-printed drug delivery platform which is able to deliver the same type of chemotherapy that you would get systemically, but without any of the side effects. Yes, that's a great question. So you can actually put it on top of the tumor. You suture it on from the 4 corners that you see, and it provides the same chemotherapy for up to 1 month. So you could be roaming around, sleeping, doing groceries, but the cancer is still getting treated.
I mean, $1 billion of revenue from 3,000 patients.